Abstract
Nurses at the bedside strive to base their practice on the best available information derived from evidence. However, issues related to patient care often arise for which evidence is either difficult to attain or not available. This can be particularly true for nurses who care for patients with diverse diagnoses because most studies focus on patients with a single cancer diagnosis. For example, evidence about quality of life (QOL) as perceived by the patient is a concern for clinicians but is of particular importance to nurses at the bedside. A great deal of study has been performed on the QOL of patients with cancer; however, most of these reports focus on narrow or limited samples, typically one specific cancer type. Having access to a registry that enrolls patients with diverse types of cancer and collects QOL data could be very useful to practicing bedside nurses.
Aregistry is a large database in which patient information is collected using sound measures in a systematic fashion, for use by researchers and clinicians with patient consent. Existing registries have served critical functions, including tracking incidence and prevalence of disease and likely causative factors, providing data for large-scale observations and measurement of outcomes for prevention and treatment, and measuring quality of care (Gliklich & Dreyer, 2010). In the United States, national support of cancer registries began in 1973 with the establishment of the Surveillance, Epidemiology, and End Results (SEER) program at the National Cancer Institute (NCI) (www.seer.cancer.gov). In 1994, the Centers for Disease Control and Prevention began the National Program of Cancer Registries (NPCR) to support and expand the initiatives began by SEER. NPCR registries collect data on cancer cases occurring among 96% of the U.S. population (www.cdc.gov/cancer/npcr). Nurses have used registries as a tool to recruit specific study populations (Foster et al., 2012; Matthews, Tejeda, Johnson, Berbaum, & Manfredi, 2012; Smith, Zimmerman, Williams, & Zebrack, 2009), but no reports exist in the literature of nurses using registry data in clinical practice. This may reflect that most current registries focus on biologic measures, such as laboratory tests and radiologic data. Despite the many uses of registries to investigate the science of cancer, only one nurse-developed psychosocial data registry, developed at Case Western Reserve University, was identified in the literature (Daly et al., 2007).
As an example of how to use a registry, a nurse who works in an inpatient oncology unit may assume, based on his or her values and work experiences, that patients with higher education and income and an early-stage cancer would have better quality of life (QOL) than those who are not educated, have a low income, and have a late-stage cancer. Based on this, a feasible question for a nurse or nurse researcher to ask would be, “Is there a relationship between demographic and clinical characteristics in patients with diverse cancer diagnoses and QOL?”
A Psychosocial Cancer Registry
Before deciding to use a registry, knowing characteristics about the enrolled patients is important. The data for the psychosocial cancer registry were collected in an outpatient clinic at the NCI– designated Seidman Cancer Center and addressed QOL in patients with diverse cancer diagnoses. To enroll in the registry, individuals met the following criteria: aged older than 18 years, have the ability to comprehend the English language, have a new diagnosis of cancer, and are receiving ongoing care at the cancer center. Exclusion criteria included cognitive impairment or immediate referral for a bone marrow or stem cell transplantation because much of that type of treatment is conducted in the inpatient setting. All cancer diagnoses and stages were included. Demographic and clinical data were gathered at enrollment, and QOL was measured using several questionnaires at enrollment and after three and nine months. During scheduled outpatient visits, patients were given the choice of faceto- face interviews or self-administration of the questionnaires. The project was approved by the hospital’s institutional review board, and data were collected from 2005–2009. Tables 1 and 2 show the characteristics of enrolled patients; gender, education, income level, and other demographic and clinical variables were well represented.
TABLE 1.
Characteristic | X̄ | SD |
---|---|---|
Age (years)a | 59.6 | 12.5 |
Characteristic | n | % |
Gender | ||
Female | 234 | 57 |
Male | 176 | 43 |
Race | ||
Caucasian | 310 | 76 |
African American, Hispanic, or other | 99 | 24 |
Missing data | 1 | <1 |
Marital status | ||
Married | 259 | 63 |
Not married | 146 | 36 |
Missing data | 5 | 1 |
Level of education | ||
Less than high school | 28 | 7 |
High school | 188 | 46 |
College | 136 | 33 |
Post college | 45 | 11 |
Missing data | 13 | 3 |
Employment status | ||
Employed | 155 | 38 |
Retired | 137 | 33 |
Not employed | 96 | 23 |
Missing data | 22 | 5 |
Income ($) | ||
20,000 or less | 78 | 19 |
20,001–49,999 | 130 | 32 |
50,000 or greater | 171 | 42 |
Missing data | 31 | 8 |
Median = 60; range = 18–90
Note. Because of rounding, not all percentages total 100.
TABLE 2.
Characteristic | n | % |
---|---|---|
Cancer type | ||
Leukemia, lymphoma, or multiple myeloma | 75 | 18 |
Lung | 69 | 17 |
Gynecologic | 49 | 12 |
Breast | 44 | 11 |
Head or neck | 41 | 10 |
Colon or rectal | 39 | 10 |
Gastrointestinal | 39 | 10 |
Prostate | 14 | 3 |
All others | 38 | 9 |
Missing data | 2 | <1 |
Cancer stage | ||
I | 52 | 13 |
II | 61 | 15 |
III | 115 | 28 |
IV | 110 | 27 |
Missing data | 72 | 18 |
Previous history of cancer | ||
Yes | 52 | 13 |
No | 347 | 85 |
Missing data | 11 | 3 |
Performance status (ECOG) | ||
0 | 144 | 35 |
1 | 173 | 42 |
2 | 43 | 10 |
3 | 18 | 4 |
Missing data | 32 | 8 |
ECOG—Eastern Cooperative Oncology Group
Note. Because of rounding, not all percentages total 100.
Nurses should know about the instruments used to capture data about various aspects of QOL, including mood state, status, and spiritual well-being. Table 3 provides a summary of validated tools that were used in this study, including tests used to measure QOL. The measurement of several aspects or dimensions of QOL is important when designing a registry useful for a variety of purposes. The Eastern Cooperative Oncology Group (ECOG) questionnaire focuses on functional status. ECOG scores from the authors’ registry ranged from 0 (able to carry out all predisease performance without restriction) to 3 (capable of only limited self-care; confined to bed or chair for more than 50% of waking hours) (Oken et al., 1982). However, overall QOL depends on more than physical well-being. This article focuses on the Functional Assessment of Cancer Therapy–General (FACT-G), an instrument widely used to assess overall QOL in patients with cancer (Brucker, Yost, Cashy, Webster, & Cella, 2005; Luckett et al., 2011). The FACT-G assesses four dimensions of QOL: physical well-being, social and family well-being, emotional well-being, and functional well-being. The test-retest reliability coefficients for the FACT-G range from 0.82–0.92 (Cella et al., 1993); scores above 0.8 are considered to have good-to-excellent reliability. The 27 items are rated on a five-point Likert-type scale ranging from 0 (not at all) to 5 (very much). A higher score on the subscales and the total score indicates a higher QOL (range of the total score = 0–108).
TABLE 3.
Instrument | Domain | Number of Items |
Range of Scores |
---|---|---|---|
Charlson Comorbidity Index | Predicts one-year mortality | 19 | 0–37 |
Eastern Cooperative Oncology Group | Performance status | 1 | 0–5 |
Functional Assessment of Cancer Therapy-General scale | Quality of life | 27 | 0–108 |
Functional Assessment of Chronic Illness Therapy-Spiritual Well-Being scale | Spirituality | 12 | 0–48 |
Profile of Mood States Short Form | Mood state | 30 | 20–100 |
Note. Based on information from Brucker et al., 2005; Chaundry et al., 2005; McNair et al., 1992; Oken et al., 1982; Peterman et al., 2002 .
Answering a Clinical Question
The results to the posed clinical question —Is there a relationship between demographic and clinical characteristics in patients with diverse cancer diagnoses and QOL?—showed that the mean and median scores of the FACT-G were 80.3 (SD = 16.2) and 82, respectively. With the exception of age (r = 0.238, p = 0.00), no statistically significant associations were found between QOL and patient characteristics; this means that patients who were older reported a higher QOL, which is similar to previous findings about QOL and age (Burfeind et al., 2008; Smith et al., 2009). Although previous studies focused on earlier-stage cancers or specific types of cancer (Brown et al., 2006; Lehto, Ojanen, & Kellokumpu-Lehtinen, 2005; Lu et al., 2007; Strasser-Weippl & Ludwig, 2008), data from the authors’ registry confirm that the association of improved QOL with older age holds across all cancer diagnoses and stages of disease.
Implications for Nursing Practice
The data from the registry suggest that nurses cannot assume that patients with a late-stage cancer or with lower income or education levels are at higher risk for impaired QOL. These findings support the importance of addressing QOL in all patients with cancer, regardless of stage or demographic characteristics. Nurse managers who plan to initiate or improve clinical programs designed to contribute to the QOL of patients undergoing cancer therapy should not target predetermined subsets of patients. Instead, screening patients on admission and throughout treatment could be a more reliable method to identify people who might benefit from more intense support.
In addition to the benefits of using registry data, limitations also exist. Despite efforts to collect a broad range of information, registry data may not match a specific research query or clinical question. Incorporating enrollment in a registry and collection of data also requires time and training of personnel. Because biologic registries are so common in cancer centers, collaborating with medical colleagues to add psychosocial data to existing registries may be a feasible approach. Incorporating small data sets in admission interviews, beginning with just one general QOL questionnaire, also can initiate a psychosocial registry. Despite these limitations, registries that include data relevant to the clinical practice of oncology nurses, as well as nurse researchers, can be an important asset to improving care.
Acknowledgments
Support for this research was provided by a Case Western Reserve University Presidential Research Initiative grant (P20-CA-103736). The authors take full responsibility for the content of the article. Kelley can be reached at carol.kelley@case.edu, with copy to editor at CJONEditor@ons.org.
References
- Brown PD, Ballman KV, Rummans TA, Maurer MJ, Sloan JA, Boeve BF, Buckner JC. Prospective study of quality of life in adults with newly diagnosed high-grade gliomas. Journal of Neuro-Oncology. 2006;76:283–291. doi: 10.1007/s11060-005-7020-9. [DOI] [PubMed] [Google Scholar]
- Brucker PS, Yost K, Cashy J, Webster K, Cella D. General population and cancer patient norms for the Functional Assessment of Cancer Therapy- General (FACT-G) Evaluation and the Health Professions. 2005;28:192–211. doi: 10.1177/0163278705275341. [DOI] [PubMed] [Google Scholar]
- Burfeind WR, Jr, Tong BC, O’Branksi E, Herndon JE, Toloza EM, D’Amico TA, Harpole DH., Jr Quality of life outcomes are equivalent after lobectomy in the elderly. Journal of Thoracic and Cardiovasular Surgery. 2008;136:597–604. doi: 10.1016/j.jtcvs.2008.02.093. [DOI] [PubMed] [Google Scholar]
- Cella DF, Tulsky DS, Gray G, Sarafian B, Linn E, Bonomi A, Brannon J. The Functional Assessment of Cancer Therapy scale: Development and validation of the general measure. Journal of Clinical Oncology. 1993;11:570–590. doi: 10.1200/JCO.1993.11.3.570. [DOI] [PubMed] [Google Scholar]
- Chaudhry S, Jin L, Meltzer D. Use of a self-report-generated Charlson Comorbidity Index for predicting mortality. Medical Care. 2005;43:607–615. doi: 10.1097/01.mlr.0000163658.65008.ec. [DOI] [PubMed] [Google Scholar]
- Daly BJ, Douglas SL, Foley H, Lipson AR, Liou CF, Bowman K, Rose J. Psychosocial registry for persons with cancer: A method of facilitating quality of life and symptom research. Psycho-Oncology. 2007;4:358–364. doi: 10.1002/pon.1091. [DOI] [PubMed] [Google Scholar]
- Foster TL, Gilmer MJ, Vannatta K, Barrera M, Davies B, Dietrich MS, Gerhardt CA. Changes in siblings after the death of a child from cancer. Cancer Nursing. 2012;35:347–354. doi: 10.1097/NCC.0b013e3182365646. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gliklich RE, Dreyer NA, editors. Registries for evaluating patient outcomes: A user’s guide. 2nd ed. Rockville, MD: Agency for Healthcare Research and Quality; 2010. [PubMed] [Google Scholar]
- Lehto US, Ojanen M, Kellokumpu-Lehtinen P. Predictors of quality of life in newly diagnosed melanoma and breast cancer patients. Annals of Oncology. 2005;16:805–816. doi: 10.1093/annonc/mdi146. [DOI] [PubMed] [Google Scholar]
- Lu W, Cui Y, Zheng Y, Gu K, Cai H, Li Q, Shu XO. Impact of newly diagnosed breast cancer on quality of life among Chinese women. Breast Cancer Research and Treatment. 2007;102:201–210. doi: 10.1007/s10549-006-9318-5. [DOI] [PubMed] [Google Scholar]
- Luckett T, King MT, Butow PN, Oguchi M, Rankin N, Price MA, Heading G. Choosing between the EORTC QLQ-C30 and FACT-G for measuring health-related quality of life in cancer clinical research: Issues, evidence and recommendations. Annals of Oncology. 2011;22:2179–2190. doi: 10.1093/annonc/mdq721. [DOI] [PubMed] [Google Scholar]
- Matthews AK, Tejeda S, Johnson TP, Berbaum ML, Manfredi C. Correlates of quality of life among African American and white cancer survivors. Cancer Nursing. 2012;35:355–364. doi: 10.1097/NCC.0b013e31824131d9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- McNair DM, Lorr M, Droppleman LF. Manual for the profile of mood states. San Diego, CA: Educational and Industrial Testing Service; 1992. [Google Scholar]
- Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, Carbone PP. Toxicity and response criteria of the Eastern Cooperative Oncology Group. American Journal of Clinical Oncology. 1982;5:649–655. [PubMed] [Google Scholar]
- Peterman AH, Fitchett G, Brady MJ, Hernandez L, Cella D. Measuring spiritual well-being in people with cancer: The Functional Assessment of Chronic Illness Therapy–Spiritual Well-being Scale (FACIT-Sp) Annals of Behavioral Medicine. 2002;24:49–58. doi: 10.1207/S15324796ABM2401_06. [DOI] [PubMed] [Google Scholar]
- Smith SK, Zimmerman S, Williams CS, Zebrack BJ. Health status and quality of life among non-Hodgkin lymphoma survivors. Cancer. 2009;115:3312–3323. doi: 10.1002/cncr.24391. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Strasser-Weippl K, Ludwig H. Psychosocial QOL is an independent predictor of overall survival in newly diagnosed patients with multiple myeloma. European Journal of Haematology. 2008;81:374–379. doi: 10.1111/j.1600-0609.2008.01126.x. [DOI] [PubMed] [Google Scholar]